Delivery Order SPE2DB22D3019-SPE2DB24FK3KA
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication for the treatment of diabetes. The contract has a ceiling value of $1,535.66 and a period of performance ending on April 17, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,884.04 firm fixed-price contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin product, with a completion date of January 16, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,196.25, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin product. It is a firm fixed price delivery order contract with an ultimate completion date of April 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus SoloStar insulin medication, a diabetes treatment, with a ceiling value of $1,022.80. The contract is a firm fixed-price delivery order, with a performance period ending on May 2, 2025. This contract is not set-aside and was awarded on May 1, 2025. AmerisourceBergen Drug...
- This is a delivery order (contract number SPE2DB20D3505|SPE2DB23FT5T3) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for LANTUS SOLOSTAR 100 UNIT/ML 3ML at a ceiling value of $1,366.67. The contract has a firm fixed price and an ultimate completion date of January 19, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,022.80 contract is for the provision of Lantus insulin medication (100U/ML, 3ML, 5 syringes) to support federal healthcare programs. The contract has a firm fixed price pricing type and a period of performance through December 20, 2024. Amerisourcebergen holds a larger $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,365.20, is for the procurement of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication used in the treatment of diabetes. The contract has a period of performance through September 2023 and does not utilize any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.80 firm-fixed-price contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The contract has an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corporation holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,003.04, is a delivery order for the pharmaceutical product Lantus SoloStar (insulin glargine) 100 unit/mL 3mL. The contract has a firm fixed price and an ultimate completion date of March 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for LANTUS SOLOSTAR 100 UNIT/ML 3ML. The contract has a ceiling value of $1,285.20 and runs through January 17, 2023. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB24FK3KADelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication, and has a ceiling value of $6,880.85. The contract is a firm fixed-price award with a completion date of May 22, 2024. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 5/21/24 |